EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study

Maria Abbattista, Addolorata Truma, Ida Martinelli, Francesca Gianniello, Serena M Passamonti, Marco Capecchi, Andrea Artoni, Flora Peyvandi, Paolo Bucciarelli

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.06.024 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Maria Abbattista und 8 weiteren Autor:innen. Beteiligte Einrichtung: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore P…. Hauptthemen laut MEDLINE: Contraceptives, Oral, Combined, Intracranial Thrombosis, Venous Thrombosis, Contraceptives, Oral, Hormonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Ministero dell'Università e della Ricerca, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cerebral vein thrombosis (CVT) is a rare manifestation of venous thrombosis predominantly affecting women due to female-specific risk factors, such as combined hormonal contraceptive (CHC) use. However, limited data exist on how different CHC types affect CVT risk. OBJECTIVES: This study aimed to evaluate CVT risk across CHC types and to investigate their combined effects with thrombophilia, family history of thrombosis, and body mass index. METHODS: This case-control study included women with CVT (cases) and healthy women (controls) of childbearing age who were referred to our Center from 1992 to 2019 for a thrombophilia work-up. Women with pregnancy- and cancer-related CVT were excluded. RESULTS: In total, 206 cases (157 CHC users, 49 nonusers) and 868 controls (196 CHC users, 672 nonusers) were included. CHC users had a 10-fold higher risk of CVT (odds ratio [OR]: 10.9; 95% CI: 7.7-15.7) than nonusers. Higher estrogen doses increased the risk in a dose-response manner. Variable estrogen dose CHC carried a 6-fold increased risk, similar to progestin-only pills. The risk increased with fourth-generation pills (OR: 28.3; 95% CI: 14.6-54.9). Thrombophilia abnormalities had a synergistic effect with CHC use (OR: 67.8; 95% CI: 34.6-133.0). For CHC users with a positive family history of thrombosis, the OR of the combined effect varied from 47.0 (95% CI: 24.4-90.7) to 254.1 (95% CI: 79.8-809.0), depending on the absence or presence of thrombophilia abnormalities. CONCLUSION: This study underscores the complex interaction between CHC type and other thrombotic risk factors in influencing CVT risk among women of childbearing age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptives, Oral, CombinedIntracranial ThrombosisVenous ThrombosisContraceptives, Oral, HormonalHumansFemaleCase-Control StudiesAdultRisk FactorsRisk AssessmentYoung AdultThrombophiliaBody Mass IndexEstrogens

Stichwörter der Autor:innen

combined oral contraceptivesintracranial thrombosisthrombophiliavenous thrombosis

Substanzen

Contraceptives, Oral, CombinedContraceptives, Oral, HormonalEstrogens

Autor:innen und Institutionen

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: maria.abbattista@policli…
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Division of Hematology, Gruppo Ospedaliero M…
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplant…

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Ministero dell'Università e della Ricerca
  • Ministry of Health

Zitieren

APA

Abbattista, M., Truma, A., Martinelli, I., Gianniello, F., Passamonti, S. M., Capecchi, M., Artoni, A., Peyvandi, F., & Bucciarelli, P. (2025). The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.06.024

Vancouver

Abbattista M, Truma A, Martinelli I, Gianniello F, Passamonti SM, Capecchi M, et al. The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.06.024

BibTeX
@article{Abbattista2025,
  author = {Abbattista, Maria and Truma, Addolorata and Martinelli, Ida and Gianniello, Francesca and Passamonti, Serena M and Capecchi, Marco and Artoni, Andrea and Peyvandi, Flora and Bucciarelli, Paolo},
  title = {The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.06.024}
}
Kostenlos starten →